Overview

Spinal Cord Neuromodulation for Spinal Cord Injury

Status:
Active, not recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
This study is designed to assess the strategy of using spinal cord stimulation to improve the ability to move in spinal cord injured humans.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of California, Los Angeles
Treatments:
Buspirone